1F3J
HISTOCOMPATIBILITY ANTIGEN I-AG7
Summary for 1F3J
Entry DOI | 10.2210/pdb1f3j/pdb |
Descriptor | H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, MHC CLASS II NOD, LYSOZYME C, ... (5 entities in total) |
Functional Keywords | histocompatibility antigen, mhc, peptide complex, immune system |
Biological source | Mus musculus (house mouse) More |
Total number of polymer chains | 6 |
Total formula weight | 90615.08 |
Authors | Latek, R.R.,Unanue, E.R.,Fremont, D.H. (deposition date: 2000-06-04, release date: 2000-09-20, Last modification date: 2024-10-30) |
Primary citation | Latek, R.R.,Suri, A.,Petzold, S.J.,Nelson, C.A.,Kanagawa, O.,Unanue, E.R.,Fremont, D.H. Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice. Immunity, 12:699-710, 2000 Cited by PubMed Abstract: We have determined the crystal structure of I-Ag7, an integral component in murine type I diabetes development. Several features distinguish I-Ag7 from other non-autoimmune-associated MHC class II molecules, including novel peptide and heterodimer pairing interactions. The binding groove of I-Ag7 is unusual at both terminal ends, with a potentially solvent-exposed channel at the base of the P1 pocket and a widened entrance to the P9 pocket. Peptide binding studies with variants of the hen egg lysozyme I-Ag7 epitope HEL(11-25) support a comprehensive structure-based I-Ag7 binding motif. Residues critical for T cell recognition were investigated with a panel of HEL(11-25)-restricted clones, which uncovered P1 anchor-dependent structural variations. These results establish a framework for future experiments directed at understanding the role of I-Ag7 in autoimmunity. PubMed: 10894169DOI: 10.1016/S1074-7613(00)80220-4 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (3.1 Å) |
Structure validation
Download full validation report